About Mediff Pharma Private Limited
Data last updated:
Mediff Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 27 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2013PTC262802. Its GSTIN is 07AAICM9896K1ZH (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ashish Gilani and Priya Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P. No. 12 Block G, Pushkar Enclave Paschim Vihar, New Delhi, Delhi, India – 110063.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.8 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹29.39 Lakh (net margin -4.3%) and EBITDA of -₹15.13 Lakh (EBITDA margin -2.2%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 50% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mediffpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressP. No. 12 Block G, Pushkar Enclave Paschim Vihar, New Delhi, Delhi, India – 110063
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mediff Pharma Private Limited
The main business activity of Mediff Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mediff Pharma Private Limited FY 2025 filings available
Mediff Pharma Private Limited reported revenue of ₹6.8 Cr (up 204% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Mediff Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 50% over five years, including 204% growth in the latest year. EBITDA fell 274% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mediff Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹15.13 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹29.39 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mediff Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -4.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mediff Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mediff Pharma Private Limited
Mediff Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Symphony Pharma Lifesciences Private Limited | ₹7.2 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Kolthur Village, Telangana, India |
| Bileshwar Pharmaceuticals Private Limited | ₹7.16 Cr (FY 2025) | •••• | •••• | -34.0% | •••• | Jhagadia, Gujarat, India |
| Gagangiri Pharma Chem Private Limited | ₹6.93 Cr (FY 2024) | •••• | •••• | 40.0% | •••• | Mumbai, Maharashtra, India |
| Dharoya Pharmaciuticales Pvt Ltd | ₹6.93 Cr (FY 2025) | •••• | •••• | -29.0% | •••• | Vadodara, Gujarat, India |
| Vindhya Pharma (India) Private Limited | ₹6.89 Cr (FY 2025) | •••• | •••• | -50.0% | •••• | Hyderabad, Telangana, India |
| Mediff Pharma Private Limited this company | ₹6.8 Cr (FY 2025) | •••• | •••• | 204.0% | •••• | New Delhi, Delhi, India |
| Cospharm Speciality Ingredients Private Limited | ₹6.77 Cr (FY 2024) | •••• | •••• | 47.0% | •••• | Pune, Maharashtra, India |
| Anant Pharmaceuticals Private Limited | ₹6.76 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Ambernath East, Maharashtra, India |
| HTS Biopharma Private Limited | ₹6.71 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Hyderabad, Telangana, India |
| Abhinandan Rasayan Private Limited | ₹6.66 Cr (FY 2018) | •••• | •••• | -37.0% | •••• | Dombivli East, Maharashtra, India |
| Alchem Synthon Private Limited. | ₹6.53 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Mediff Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mediff Pharma Private Limited
Mediff Pharma Private Limited is audited by SHUBHANGI GOEL & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHUBHANGI GOEL & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mediff Pharma Private Limited
Mediff Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Gilani Also directs: Aurionvest Ventures Private Limited | Director | 27 Dec 2013 | 12 Years 9 Months | Current |
| Sumedha Gilani | Additional Director | 27 Jan 2020 | 6 Years 8 Months | Current |
| Priya Kumari Also directs: Aurionvest Ventures Private Limited | Director | 06 Sep 2022 | 4 Years 1 Months | Current |
Ownership and Shareholding of Mediff Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mediff Pharma Private Limited
Mediff Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Mediff Pharma Private Limited
Employment history and EPFO contributions of people linked to Mediff Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mediff Pharma Private Limited
Mediff Pharma Private Limited has 5 board changes on record since 2013: 3 appointments and 2 cessations. The latest: Ashish Gilani ceased to be Director on 06 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Mediff Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mediff Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mediff Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mediff Pharma Private Limited
Mediff Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICM9896K1ZH | Delhi | Active | 01 Jul 2017 |
| 06AAICM9896K1ZJ | Haryana | Active | 24 Jul 2024 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mediff Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mediff Pharma Private Limited
Mediff Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 27 December 2013 (13+ years old) and is registered under CIN U85100DL2013PTC262802.
Mediff Pharma reported revenue of ₹6.8 Cr for FY 2025 (up 204% YoY).
Mediff Pharma has 3 current directors:
- Ashish Gilani - Director
- Sumedha Gilani - Additional Director
- Priya Kumari - Director
Mediff Pharma reported a net loss of ₹29.39 Lakh (net margin -4.3%) and EBITDA of -₹15.13 Lakh (EBITDA margin -2.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mediff Pharma is 40% over three years and 50% over five years. In the latest year (FY 2025) revenue rose 204%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mediff Pharma is 07AAICM9896K1ZH, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAICM9896K1ZJ (Haryana).
The CIN (Corporate Identification Number) of Mediff Pharma is U85100DL2013PTC262802. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediff Pharma was incorporated on 27 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Mediff Pharma by revenue are Symphony Pharma Lifesciences Private Limited, Bileshwar Pharmaceuticals Private Limited, Gagangiri Pharma Chem Private Limited, Dharoya Pharmaciuticales Pvt Ltd, Vindhya Pharma (India) Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Ashish Gilani ceased to be Director on 06 Sep 2022. Priya Kumari was appointed as Director on 06 Sep 2022. Pikun Gangwani ceased to be Director on 27 Jan 2020. Mediff Pharma has 5 board changes on record in total.
Mediff Pharma can be reached through the website mediffpharma.com. Its registered office is in New Delhi, Delhi, India.